Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to share news the company has obtained public reimbursement from the Quebec Government for its product Onstryv. Saviuk telling Proactive Onstryv is approved by Health Canada as an add-on therapy for the treatment of the signs and symptoms of idiopathic Parkinson's Disease.
Valeo Pharma announces its product Onstryv receives public reimbursement in Quebec
